Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.

Controlled oxygen delivery to power tissue regeneration

Open access

Abstract

Oxygen plays a crucial role in human embryogenesis, homeostasis, and tissue regeneration. Emerging engineered regenerative solutions call for novel oxygen delivery systems. To become a reality, these systems must consider physiological processes, oxygen release mechanisms and the target application. In this review, we explore the biological relevance of oxygen at both a cellular and tissue level, and the importance of its controlled delivery via engineered biomaterials and devices. Recent advances and upcoming trends in the field are also discussed with a focus on tissue-engineered constructs that could meet metabolic demands to facilitate regeneration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-024-48719-x

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The key role of oxygen in driving tissue regeneration is an interplay between biological considerations, delivery from biological molecules and chemicals, and the delivery strategy. Organogenesis and biological processes can be classified according to the developmental stage (pre-natal and post-natal), with events such as tissue regeneration occurring at the post-natal stage. Delivery strategies can be device- or material-dependent, with some strategies overlapping these two. Molecules and chemicals that produce oxygen can be naturally derived (organic) or inorganic (such as peroxides). Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
Fig. 1 The key role of oxygen in driving tissue regeneration is an interplay between biological considerations, delivery from biological molecules and chemicals, and the delivery strategy. Organogenesis and biological processes can be classified according to the developmental stage (pre-natal and post-natal), with events such as tissue regeneration occurring at the post-natal stage. Delivery strategies can be device- or material-dependent, with some strategies overlapping these two. Molecules and chemicals that produce oxygen can be naturally derived (organic) or inorganic (such as peroxides). Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.CC BY · PubMed Central
Fig. 2 Oxygen in development and HIF-1α regulation. a The role of oxygen in development starts from embryonic development up to post-natal phase. Early hypoxic conditions trigger HIF1-a accumulation, thus targeting genes associated with vascularization (such as VEGF) to encourage organ formation and placental-fetus interactions. After the placenta is formed, oxygen levels rise up to 38 mmHg. b During normoxia, HIF-1a is regulated by prolyl hydroxylation. The HIF1-a subunits contain three sites for hydroxylation (two on prolyl residues within the oxygen-dependent degradation domain (ODDD) and one on an asparaginyl residue within the C-terminal transactivation domain (C-TAD)). Upon oxygen-dependent Fe(II)-, oxygen-, and 2-oxoglutarate, PHDs facilitate prolyl hydroxylation. This is then recognized by the von Hippel-Lindau protein (pVHL), which then marks it for degradation through a process called ubiquitination, leading to its breakdown by the proteasome. Separately, the asparaginyl hydroxylation process is driven by an enzyme called factor-inhibiting HIF (FIH) acting on a specific site in the C-TAD. In hypoxia, when the hydroxylation is suppressed or PHDs are inhibited, HIF-1a is translocated into the nucleus, where it heterodimerises with HIF1-b subunit allowing binding to hypoxia-response elements (HREs). Adapted from124. Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
Fig. 2 Oxygen in development and HIF-1α regulation. a The role of oxygen in development starts from embryonic development up to post-natal phase. Early hypoxic conditions trigger HIF1-a accumulation, thus targeting genes associated with vascularization (such as VEGF) to encourage organ formation and placental-fetus interactions. After the placenta is formed, oxygen levels rise up to 38 mmHg. b During normoxia, HIF-1a is regulated by prolyl hydroxylation. The HIF1-a subunits contain three sites for hydroxylation (two on prolyl residues within the oxygen-dependent degradation domain (ODDD) and one on an asparaginyl residue within the C-terminal transactivation domain (C-TAD)). Upon oxygen-dependent Fe(II)-, oxygen-, and 2-oxoglutarate, PHDs facilitate prolyl hydroxylation. This is then recognized by the von Hippel-Lindau protein (pVHL), which then marks it for degradation through a process called ubiquitination, leading to its breakdown by the proteasome. Separately, the asparaginyl hydroxylation process is driven by an enzyme called factor-inhibiting HIF (FIH) acting on a specific site in the C-TAD. In hypoxia, when the hydroxylation is suppressed or PHDs are inhibited, HIF-1a is translocated into the nucleus, where it heterodimerises with HIF1-b subunit allowing binding to hypoxia-response elements (HREs). Adapted from124. Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.CC BY · PubMed Central
Fig. 3 Oxidative phosphorylation, ROS generation, pathology, and redox signaling. a During oxidative phosphorylation, electron carriers NAD+ and FAD feed electrons to the ETC at either complex I or II. The electrons are shuttled through four membrane-bound protein complexes, referred to as complexes I-IV, which undergo a series of redox reactions. Through this process electrons from complexes I and II also enter the `Q-cycle', where they are passed to another electron carrier, ubiquinone (Q), to facilitate transfer to cytochrome c (via complex III as an intermediary). Diatomic oxygen binds to Complex IV, where it accepts the electrons carried by cytochrome C and is reduced to water. Energy released through these reactions facilitates an electrochemical proton gradient, or mitochondrial membrane potential, within the intermembrane space. To relieve this membrane potential, protons can reenter into the mitochondrial matrix through another protein complex, ATP synthase, which harnesses the mechanical energy generated by the movement of protons to overcome energy constrictions limiting the conversion of adenosine diphosphate (ADP) into ATP. “Leaky" electrons result in the generation of ROS. Adapted from ref. 125. b Oxygen is involved in both redox signaling and pathology in the form of ROS. A number of sources, both endogenous and exogenous, are capable of generating cellular ROS. H2O2 is involved in the signal transduction of pathways that control cell growth, proliferation, apoptosis, and differentiation. However, most ROS species, particularly HO•-, facilitate oxidative stress, cell damage, inflammation and, subsequently, disease. Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
Fig. 3 Oxidative phosphorylation, ROS generation, pathology, and redox signaling. a During oxidative phosphorylation, electron carriers NAD+ and FAD feed electrons to the ETC at either complex I or II. The electrons are shuttled through four membrane-bound protein complexes, referred to as complexes I-IV, which undergo a series of redox reactions. Through this process electrons from complexes I and II also enter the `Q-cycle', where they are passed to another electron carrier, ubiquinone (Q), to facilitate transfer to cytochrome c (via complex III as an intermediary). Diatomic oxygen binds to Complex IV, where it accepts the electrons carried by cytochrome C and is reduced to water. Energy released through these reactions facilitates an electrochemical proton gradient, or mitochondrial membrane potential, within the intermembrane space. To relieve this membrane potential, protons can reenter into the mitochondrial matrix through another protein complex, ATP synthase, which harnesses the mechanical energy generated by the movement of protons to overcome energy constrictions limiting the conversion of adenosine diphosphate (ADP) into ATP. “Leaky" electrons result in the generation of ROS. Adapted from ref. 125. b Oxygen is involved in both redox signaling and pathology in the form of ROS. A number of sources, both endogenous and exogenous, are capable of generating cellular ROS. H2O2 is involved in the signal transduction of pathways that control cell growth, proliferation, apoptosis, and differentiation. However, most ROS species, particularly HO•-, facilitate oxidative stress, cell damage, inflammation and, subsequently, disease. Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.CC BY · PubMed Central
Fig. 4 General biochemical and redox properties of globins and delivery strategies. a The oligomeric state and heme coordination properties of all four human globins. The X-ray crystal structure of tetrameric hemoglobin (Hb) displays the b1 subunit as a ribbon structure, while the entire structure of monomeric myoglobin (Mb) is shown as a ribbon, positioned relative to Hb b1. The coordinated heme is highlighted in cyan in both structures. b Structural properties of five-coordinate heme-bound Fe(II) (Hb and Mb) binding to oxygen. In the deoxy conformation, Fe(II) sits out of plane from the tetradentate heme. Oxygen binding facilitates shift to stable, tetrahedral geometry in oxyhemoglobin. c oxygen binding properties of Hb and Mb. Hb exhibits cooperative binding as the oligomers transition from T-state to R-state after one oxygen binds. Mb exhibits hyperbolic binding because it functions as a monomer. d Redox properties of oxygen coordination to heme. e Strategies adopted to modify or delivery globins for use as an artificial blood supply. Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
Fig. 4 General biochemical and redox properties of globins and delivery strategies. a The oligomeric state and heme coordination properties of all four human globins. The X-ray crystal structure of tetrameric hemoglobin (Hb) displays the b1 subunit as a ribbon structure, while the entire structure of monomeric myoglobin (Mb) is shown as a ribbon, positioned relative to Hb b1. The coordinated heme is highlighted in cyan in both structures. b Structural properties of five-coordinate heme-bound Fe(II) (Hb and Mb) binding to oxygen. In the deoxy conformation, Fe(II) sits out of plane from the tetradentate heme. Oxygen binding facilitates shift to stable, tetrahedral geometry in oxyhemoglobin. c oxygen binding properties of Hb and Mb. Hb exhibits cooperative binding as the oligomers transition from T-state to R-state after one oxygen binds. Mb exhibits hyperbolic binding because it functions as a monomer. d Redox properties of oxygen coordination to heme. e Strategies adopted to modify or delivery globins for use as an artificial blood supply. Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.CC BY · PubMed Central
Fig. 5 Controlled delivery strategies, oxygen release mechanisms and challenges in the field. a Oxygen-controlled release strategies include physical entrapment in emulsions of monodiperse size (e.g., microfluidic-generated) or polydispersed (particle dependent on velocity and shear of the system) generating particles such as micelles or multi-layered particles. Other strategies include scaffold encapsulation and stimuli-dependent release. b Core release mechanisms for biomaterials and devices able to generate oxygen. c Remaining challenges in the field of oxygen tissue engineering. Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
Fig. 5 Controlled delivery strategies, oxygen release mechanisms and challenges in the field. a Oxygen-controlled release strategies include physical entrapment in emulsions of monodiperse size (e.g., microfluidic-generated) or polydispersed (particle dependent on velocity and shear of the system) generating particles such as micelles or multi-layered particles. Other strategies include scaffold encapsulation and stimuli-dependent release. b Core release mechanisms for biomaterials and devices able to generate oxygen. c Remaining challenges in the field of oxygen tissue engineering. Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 155 references

Cited by

See all 89

Metadata

Authors
Zoneff, E., Wang, Y., Jackson, C., Smith, O., Duchi, S., Onofrillo, C., Farrugia, B., Moulton, S. E., Williams, R., Parish, C., Nisbet, D. R., & Caballero-Aguilar, L. M.
Affiliations
  • The University of Melbourne (AU)
  • Australian National University (AU)
  • St Vincent's Hospital Melbourne (AU)
  • Deakin University (AU)
Corresponding author
Nisbet, David R.
Venue
Nature Communications
Published
2024-05-22
Volume
15
Issue
1
Pages
4361-4361
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4398201307
Cited by
89
References
155
Citations by year
2026: 38 · 2025: 46 · 2024: 5
FWCI
9.87
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Deakin Research Online (Deakin University) (cc-by)
Funders
Australian Research Council
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
Keywords
oxygen delivery, tissue regeneration, engineered biomaterials, tissue-engineered constructs
MeSH terms
Animals, Biocompatible Materials, Humans, Oxygen, Regeneration, Tissue Engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Controlled oxygen delivery to power tissue regeneration. https://app.cochat.ai/papers/10.1038/s41467-024-48719-x
The paper
Zoneff, E., Wang, Y., Jackson, C., Smith, O., Duchi, S., Onofrillo, C., Farrugia, B., Moulton, S. E., Williams, R., Parish, C., Nisbet, D. R., & Caballero-Aguilar, L. M. (2024). Controlled oxygen delivery to power tissue regeneration. Nature Communications. https://doi.org/10.1038/s41467-024-48719-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.